ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the ...

Excimer laser complements Visumax 800 with Zeiss’s SMILE pro. Zeiss Medical Technology (ZMT) has announced that its MEL® 90 ophthalmology system has received approval from the U.S. Food and Drug ...

MEL 90 is integrated with the German company’s Corneal Refractive Workflow ecosystem, which encompasses the VISUMAX 800 femtosecond laser with SMILE PRO for refractive surgeries. These ...

JPMorgan analyst Anchal Verma adjusted the price target on Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY) to €41.00, up from the previous €40.00, while maintaining an Underweight rating on the stock. The ...

Despite revenue growth and strategic advancements, Carl Zeiss Meditec AG (CZMWF) faces margin pressures and market uncertainties, particularly in China.

Nevertheless, we were able to post slight growth thanks to the DORC acquisition. The good response to the new products, the approval of our VISUMAX ® 800 refractive laser system for the Chinese market ...

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without ...

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow JENA, Germany and SHANGHAI, Feb. 26, 2025 /PRNewswire/ ...